新兴的概念在致病发育,多组学应用,和临床研究在淋巴管oleiomyomatosis的临床研究
Jane J Yu1, Nishant Gupta1, Minzhe Guo2
1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
淋巴结核病 (LAM) 是一种罕见的肺部疾病. 最近的进展,包括FDA批准的治疗和指导方针,为新的生物标志物和治疗提供了希望.
科学领域:
- 肺部医学 肺部医学
- 在瘤学瘤学.
- 罕见疾病 罕见疾病
背景情况:
- 淋巴细胞结核病 (LAM) 是一种罕见的,女性占主导地位的瘤.
- 它的特征是肺部异常的光滑肌肉样细胞透,导致囊性变化和呼吸衰竭.
研究的目的:
- 要突出最近的研究和临床护理的淋巴细胞瘤瘤学 (LAM) 的进展.
- 强调推动罕见肺病进展的协作努力.
主要方法:
- 审查LAM研究和临床实践的最新发展.
- 生物信息学和实验方法的整合.
主要成果:
- 开发一种FDA批准的治疗方法来治疗LAM.
- 建立一个诊断生物标志物和一个全球临床网络.
- 为LAM管理制定临床实践指南.
结论:
- LAM作为罕见肺病进展的模型.
- 目前正在进行的研究有望在不久的将来为LAM提供新的生物标志物和治疗方法.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
07:36Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
相关概念视频
Development of the Lymphatic System
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Genomics
PI3K/mTOR/AKT Signaling Pathway
